Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline biologicals s.a. - live attenuated measles virus(schwarz strain), live attenuated mumps virus(rit 4385 strain), live attenuated rubella virus(wistar ra 27/3 strain) - powder lyophilized and solvent for solution for injection - not less than 103.0ccid50/dose+ not less than 103.7ccid50/dose+ not less than 103.0ccid50/dose

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline biologicals s.a. - live attenuated measles virus(schwarz strain), live attenuated mumps virus(rit 4385 strain), live attenuated rubella virus(wistar ra 27/3 strain) - powder lyophilized and solvent for solution for injection - not less than 103.0ccid50/dose+ not less than 103.7ccid50/dose+ not less than 103.0ccid50/dose

United States - English - NLM (National Library of Medicine)

photocure inc - hexaminolevulinate hydrochloride (unii: d4f329sl1o) (hexaminolevulinate - unii:g7h20tki67) - hexaminolevulinate hydrochloride 100 mg in 50 ml - cysview is an optical imaging agent indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy. cysview is used with the karl storz d-light c photodynamic diagnostic (pdd) system to perform cystoscopy with the blue light setting (mode 2) as an adjunct to the white light setting (mode 1). cysview is not: - a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer [see warnings and precautions (5.2) ]. - for repetitive use. the potential risks associated with repetitive exposure, including sensitization and adverse effects of blue light have not been evaluated [see warnings and precautions (5.1) ]. cysview is contraindicated in patients with: - porphyria - gross hematuria - bcg immunotherapy or intravesical chemotherapy within the past 90 days - known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid pregnancy

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - human papillomavirus type 6 l1 protein, human papillomavirus type 11 l1 protein, human papillomavirus type 16 l1 protein, human papillomavirus type 18 l1 protein - papillomavirus infections; uterine cervical dysplasia; condylomata acuminata; immunization - vaccines - gardasil is a vaccine for use from the age of 9 years for the prevention of:premalignant genital lesions (cervical, vulvar and vaginal), premalignant anal lesions, cervical cancers and anal cancers causally related to certain oncogenic human papillomavirus (hpv) types;genital warts (condyloma acuminata) causally related to specific hpv types.see sections 4.4 and 5.1 for important information on the data that support this indication.the use of gardasil should be in accordance with official recommendations.

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - measles virus enders’ edmonston strain (live, attenuated), mumps virus jeryl lynn (level b) strain (live, attenuated), rubella virus wistar ra 27/3 strain (live, attenuated) - rubella; mumps; immunization; measles - vaccines - m-m-rvaxpro is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months or older. for use in measles outbreaks, or for post-exposure vaccination, or for use in previously unvaccinated children older than 12 months who are in contact with susceptible pregnant women, and persons likely to be susceptible to mumps and rubella.,

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - virus, live attenuated, measles, virus, live attenuated, mumps, virus, live attenuated, rubella, virus, live attenuated, varicella - chickenpox; rubella; measles; mumps; immunization - vaccines - proquad is indicated for simultaneous vaccination against measles, mumps, rubella and varicella in individuals from 12 months of age. proquad can be administered to individuals from 9 months of age under special circumstances (e.g., to conform with national vaccination schedules, outbreak situations, or travel to a region with high prevalence of measles.,

Austria - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril

Spain - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril

France - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril

Italy - English - HMA (Heads of Medicines Agencies)

le vet b.v - benazepril hydrochloride 5 mg - tablet - dogs non food - benazepril